Project Grant HT9425261E236
Award Date 6/1/26
Completion Date 5/31/27
Dollars Obligated $348K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
- Federal Grant Award Summary The University of Pennsylvania received a $1,305,270 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to establish the Ovarian Cancer Academy: Advancing Ovarian Cancer Research Through Mentorship, Networking, and Collaborations. The four-year award, which commenced on September 30, 2025 and extends through September 29, 2029, will be performed at the university's Philadelphia campus. This...
- Federal Grant Award Summary The University of Pennsylvania received a $1.625 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2029. The award funds the GO-DOVER (Diagnosing Ovarian Cancer Earlier Through a Clinician Nudge to Gynecologic Oncology Referral) randomized clinical trial, a four-year research initiative conducted in Philadelphia, Pennsylvania. This study...
- Federal Project Grant Award Summary The University of Pennsylvania received a $812,487 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2025, with an ultimate completion date of September 29, 2028. The award supports research titled "Modulating Liver Inflammation to Improve Outcomes in Pancreatic Cancer," to be conducted at the university's Philadelphia campus. Under this three-year...
- Federal Project Grant Award Summary The University of Pennsylvania received a $1,159,317 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025 through June 30, 2029. The award funds the EDISYN-LFS (Early Detection in Syndromic Neoplasms for Patients with Li-Fraumeni Syndrome) initiative, which focuses on advancing early detection and diagnostic capabilities for cancer patients with Li-Fraumeni Syndrome, a...
- Federal Grant Award Summary The University of Pennsylvania received a $499,971 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) with an award date of September 30, 2026, and completion date of June 29, 2028. The project involves repurposing a cancer-approved drug to ameliorate Duchenne muscular dystrophy (DMD) pathology, representing a translational research initiative that applies existing oncology therapeutics to...
- Federal Grant Award Summary The University of Pennsylvania received a $581,220 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2028. The award supports research titled "Accelerating Post-Traumatic Epilepsy Research Through Data Integration and Verifiable Analysis at Scale," which will be conducted in Philadelphia, Pennsylvania. This modification adds $74,588...
- Federal Grant Award Summary The University of Pennsylvania received a $946,873 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2025 through June 30, 2028. The research project, titled "Genetic Risk of Prostate Cancer in Self-Identified Black Veterans," investigates genetic and pathological factors associated with prostate cancer susceptibility and progression in Black veteran...
- This federal Project Grant award in the amount of $1,605,638.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a private research university and academic medical center. The grant funding supports research aimed at developing new methods for immune targeting of dormant tumor...
- Federal Grant Award Summary Pennsylvania State University, operating through Penn State Milton S. Hershey Medical Center, received a $770,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) beginning June 1, 2026 and concluding May 31, 2028. The award funds research investigating oxytocin as a therapeutic intervention strategy in Parkinson's disease, representing a fundamental biomedical research initiative aligned with the...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Institute For Cancer Research a $1,959,353 project grant effective September 1, 2025 through August 31, 2029, under the Military Medical Research and Development program (CFDA 12.420). This award supports clinical research investigating pembrolizumab maintenance therapy following enfortumab vedotin/pembrolizumab induction treatment in front-line metastatic urothelial carcinoma. The research will be conducted at the...